Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

Open access
on behalf of the MAGNIMS study group, Sastre-Garriga, Jaume, Pareto, Deborah, Battaglini, Marco, Rocca, Maria A., Ciccarelli, Olga, Enzinger, Christian, Wuerfel, Jens, Sormani, Maria P., Barkhof, Frederik, Yousry, Tarek A., De Stefano, Nicola, Tintoré, Mar, Filippi, Massimo, Gasperini, Claudio, Kappos, Ludwig, Río, Jordi, Frederiksen, Jette, Palace, Jackie, Vrenken, Hugo, Montalban, Xavier, Rovira, Àlex·2020·Nature Reviews Neurology

Abstract

Early evaluation of treatment response and prediction of disease evolution are key issues in the management of people with multiple sclerosis (MS). In the past 20 years, MRI has become the most useful paraclinical tool in both situations and is used clinically to assess the inflammatory component of the disease, particularly the presence and evolution of focal lesions — the pathological hallmark of MS. However, diffuse neurodegenerative processes that are at least partly independent of inflammatory mechanisms can develop early in people with MS and are closely related to disability. The effects of these neurodegenerative processes at a macroscopic level can be quantified by estimation of brain and spinal cord atrophy with MRI. MRI measurements of atrophy in MS have also been proposed as a complementary approach to lesion assessment to facilitate the prediction of clinical outcomes and to assess treatment responses. In this Consensus statement, the Magnetic Resonance Imaging in MS (MAGNIMS) study group critically review the application of brain and spinal cord atrophy in clinical practice in the management of MS, considering the role of atrophy measures in prognosis and treatment monitoring and the barriers to clinical use of these measures. On the basis of this review, the group makes consensus statements and recommendations for future research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41582-020-0314-x

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 163 references

Cited by

See all 273

Metadata

Authors
on behalf of the MAGNIMS study group, Sastre-Garriga, J., Pareto, D., Battaglini, M., Rocca, M. A., Ciccarelli, O., Enzinger, C., Wuerfel, J., Sormani, M. P., Barkhof, F., Yousry, T. A., De Stefano, N., Tintoré, M., Filippi, M., Gasperini, C., Kappos, L., Río, J., Frederiksen, J., Palace, J., Vrenken, H., Montalban, X., & Rovira, À.
Venue
Nature Reviews Neurology
Published
2020-02-24
Volume
16
Issue
3
Pages
171-182
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
OpenAlex
W3008600501
Cited by
273
References
163
FWCI
8.59
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. https://app.cochat.ai/papers/10.1038/s41582-020-0314-x
The paper
on behalf of the MAGNIMS study group, Sastre-Garriga, J., Pareto, D., Battaglini, M., Rocca, M. A., Ciccarelli, O., Enzinger, C., Wuerfel, J., Sormani, M. P., Barkhof, F., Yousry, T. A., De Stefano, N., Tintoré, M., Filippi, M., Gasperini, C., Kappos, L., Río, J., Frederiksen, J., Palace, J., . . . Rovira, À. (2020). MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nature Reviews Neurology. https://doi.org/10.1038/s41582-020-0314-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.